Published 2 days ago • loading... • Updated 2 days agoShow Less IconXencor: Bullish On Their Increasingly In-House Pipeline (NASDAQ:XNCR) Summary by Seeking AlphaXencor is shifting from licensing optionality toward a broader portfolio of in-house assets across oncology and immunology. Read more on XNCR stock here.Share menu1 Articles1 ArticlesAllLeftCenterRight1Search IconSort IconSeeking AlphaLean RightFactualityOwnershipXencor: Bullish On Their Increasingly In-House Pipeline (NASDAQ:XNCR)Xencor is shifting from licensing optionality toward a broader portfolio of in-house assets across oncology and immunology. Read more on XNCR stock here.2 days ago·Ra'anana, IsraelRead Full ArticleThink freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribeBlindspot Title And LogoStories disproportionately reported by the Left or the RightSee More BlindspotsCoverage DetailsTotal News Sources1Leaning Left0Leaning Right1Center0Last Updated2 days agoBias Distribution100% RightBias Distribution Too Big Arrow IconToo Big Arrow IconCaret Up Icon100% of the sources lean Right100% RightR 100%Factuality Info IconTo view factuality data please Upgrade to PremiumOwnership Info IconTo view ownership data please Upgrade to VantageSeeking Alpha broke the news in Ra'anana, Israel 2 days ago on Tuesday, July 14, 2026.Too Big Arrow IconCaret Down IconSources are mostly out of (0)Similar News TopicsThousand Oaks Plus IconShow AllBlindspot Title And LogoStories disproportionately reported by the Left or the RightSee More BlindspotsSimilar News TopicsThousand Oaks Plus IconShow All